Klick scoops up Google health­care chief for new lead­ing role

3 years ago
Pharma
Marketing

As No­vo Nordisk be­gins PhII sick­le cell tri­al, it snags a lat­er-stage blood dis­or­der drug in $1.1B For­ma buy

3 years ago
Deals
Pharma

Ahead of #ES­MO22: An­a­lysts poke at Gilead’s Trodelvy OS; Am­gen and Mi­rati try to out-KRAS each oth­er

3 years ago
R&D

In wake of third straight mid-stage set­back, Anap­tys­Bio looks to punt IL-36 drug — even as PhI­II goes on

3 years ago
R&D

Up­dat­ed: As­traZeneca wins last-minute in­junc­tion to tem­porar­i­ly stop for­mer ex­ec from start­ing GSK job

3 years ago
People
Pharma

Mor­phoSys woos Mer­ck KGaA vet to lead late-stage push for block­buster prospect

3 years ago
People

NI­BR chief Jay Brad­ner joins the ex­o­dus at No­var­tis, hand­ing the keys to Fiona Mar­shall

3 years ago
People

Fed­er­al judge rules against FDA in ma­jor stem cell over­sight case

3 years ago
FDA+
Law

Once val­ued at more than $5B, Intar­cia Ther­a­peu­tics sees all of its ex­ecs de­part and its fi­nal shot at FDA de­nied

3 years ago
Pharma
FDA+

An­nu­al brand plan­ning un­der­way, but it’s about time for a dis­rup­tion, says for­mer Big Phar­ma com­mer­cial leader

3 years ago
Pharma
Marketing

Cur­rax dou­bles down on ‘pi­o­neer’ weight-loss med Con­trave in new­ly en­er­gized obe­si­ty drug mar­ket

3 years ago
Pharma
Marketing

West Phar­ma­ceu­ti­cal adds $65M and 225 jobs to Penn­syl­va­nia-based man­u­fac­tur­ing site

3 years ago
Manufacturing

Sanofi's Paul Hud­son scores an FDA OK for a rare dis­ease drug — af­ter a lengthy R&D odyssey

3 years ago
Pharma
FDA+

ICER reaf­firms Qsymia as most cost-ef­fec­tive obe­si­ty treat­ment in fi­nal re­port

3 years ago
Pharma

A $280M life sci­ence fa­cil­i­ty is com­ing to Col­orado as it gains more in­ter­est from biotech de­vel­op­ers

3 years ago
R&D
Pharma

FDA clears Pfiz­er and Mod­er­na's bi­va­lent boost­ers, seek­ing to slow the next wave of Omi­cron

3 years ago
Coronavirus

Af­ter dis­ap­point­ing Wall Street last year, De­nali touts new bio­mark­er da­ta hop­ing to forge clear path to FDA

3 years ago
R&D
FDA+

Af­ter ditch­ing elec­tric ve­hi­cle parts mak­er, a SPAC choos­es a Brown spin­out that had test­ed the IPO wa­ters

3 years ago
Deals

Sau­di an­ti-ag­ing group links up with AFAR to dole out re­search grants; US cannabis biotech se­cures UK part­ner

3 years ago
News Briefing

‘Share­hold­ers de­serve bet­ter’: Mereo lays off em­ploy­ees, push­es back against lead stake­hold­er's shake­up ...

3 years ago
People

Im­muno­Gen push­es read­out of rare blood can­cer tri­al to 2024

3 years ago
R&D

US ex­pects to soon run out of gov­ern­ment Covid-19 funds for vac­cines, treat­ments

3 years ago
Coronavirus

De­spite mar­ket head­winds, life sci­ences re­al es­tate is still on the rise, new re­port says

3 years ago
R&D

No­var­tis' En­tresto in­fringes on uni­ver­si­ty patents, law­suit claims

3 years ago
Pharma
Law
First page Previous page 469470471472473474475 Next page Last page
A service from the Financial Times